» Authors » Jennifer Mellor

Jennifer Mellor

Explore the profile of Jennifer Mellor including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 88
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Anderson J, Soteres D, Tachdjian R, Mellor J, Earl L, Connolly H, et al.
Allergy Asthma Proc . 2024 Sep; 45(6):426-433. PMID: 39293940
Hereditary angioedema (HAE) is a rare genetic disorder characterized by painful, debilitating, and potentially fatal swelling attacks. Lanadelumab is approved as long-term prophylaxis (LTP) in patients with HAE. However, real-world...
2.
Anderson J, Soteres D, Mellor J, Connolly H, Wynne-Cattanach K, Earl L, et al.
Allergy Asthma Proc . 2024 Jul; 45(4):247-254. PMID: 38982603
Hereditary angioedema (HAE) is a rare genetic condition characterized by painful and often debilitating swelling attacks. Little is known about the differences in outcomes between patients with HAE types I...
3.
Gebrehiwet P, Brekke J, Rudnicki S, Mellor J, Wright J, Earl L, et al.
Amyotroph Lateral Scler Frontotemporal Degener . 2023 Dec; 25(3-4):345-357. PMID: 38156828
Objective: To determine the average time from Amyotrophic Lateral Sclerosis (ALS) symptom onset to 11 pre-defined milestones, overall and according to ALS progression rate and geographic location. Methods: Data were...
4.
Wilson K, Rich C, Hakimi Z, Horneff R, Fishman J, Mellor J, et al.
Eur J Haematol . 2023 Nov; 112(4):516-529. PMID: 37994576
Objectives: To describe real-world use/effectiveness of pegcetacoplan (PEG) in paroxysmal nocturnal haemoglobinuria (PNH). Methods: Data were drawn from the Adelphi PNH Disease Specific Programme™, a cross-sectional survey conducted in France,...
5.
Goyal N, Bonar K, Savic N, Beau Lejdstrom R, Wright J, Mellor J, et al.
Amyotroph Lateral Scler Frontotemporal Degener . 2023 Oct; 25(1-2):16-25. PMID: 37794794
Objective: Delays in amyotrophic lateral sclerosis (ALS) diagnosis can result in compromised disease management and unnecessary costs. We examined the extent of ALS misdiagnosis in the US and Europe. Methods:...
6.
Stenson K, OCallaghan L, Mellor J, Wright J, Gibson G, Earl L, et al.
J Neurol Sci . 2023 Aug; 452:120764. PMID: 37639764
People with amyotrophic lateral sclerosis (pALS) require complex, multi-disciplinary care, resulting in extensive healthcare resource utilization (HCRU). To investigate the relationship between HCRU and ALS progression, the study objectives were...
7.
Mellor J, Cunningham P, Britton E, Walker L
J Aging Soc Policy . 2023 Mar; 36(5):1026-1044. PMID: 36857515
Many state Medicaid programs contract with managed care organizations to deliver long-term services and supports (LTSS) to seniors and persons with disabilities. Managed LTSS (MLTSS) programs are often intended to...
8.
Pillas D, Klein A, Gasalla T, Avbersek A, Thompson A, Wright J, et al.
Front Neurol . 2022 Jul; 13:821570. PMID: 35865639
Progressive supranuclear palsy (PSP) is a rare, relentlessly progressive, ultimately fatal neurodegenerative brain disease. The objective of this study was to assess the burden of PSP on patients, caregivers, and...
9.
Claassen D, DeCourcy J, Mellor J, Johnston C, Iyer R
J Health Econ Outcomes Res . 2021 Jun; 8(1):99-105. PMID: 34183975
Chorea is recognized as a prototypic motor feature of Huntington's disease (HD), but its effect on health-related quality of life (HRQoL) has not been fully explored. This study describes the...
10.
Nalamachu S, Robinson R, Viktrup L, Cappelleri J, Bushmakin A, Tive L, et al.
J Pain Res . 2020 Dec; 13:3415-3425. PMID: 33380823
Purpose: The purpose of this study was to assess how patient-reported pain is related to osteoarthritis (OA) treatment patterns in routine clinical practice. Patients And Methods: Data were collected between...